Skip to search formSkip to main contentSkip to account menu

CGS 10746B

Known as: CGS-10746-B, CGS-10746B 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiazepines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Rats become acutely tolerant to cathine after amphetamine or cathinone administration
The drug discrimination paradigm was used to evaluate in rats the ability of the discriminate response to either 0.8 mg/kgd… 
2001
2001
Effects of CGS 10746B on hyperactivity and place preference induced by morphine
Highly Cited
1998
Highly Cited
1998
CGS 10746B, a Novel Dopamine Release Inhibitor, Blocks the Establishment of Cocaine and MDMA Conditioned Place Preferences
1993
1993
Cocaine discrimination is attenuated by isradipine and CGS 10746B
1992
1992
Effect of altering dopamine or serotonin neurotransmitters upon cathinone discrimination
1992
1992
Psychostimulant-induced activity is attenuated by two putative dopamine release inhibitors
1991
1991
Effect of learned behavior upon conditioned place preference to cathinone
1988
1988
Presynaptic inhibition of nigrostriatal dopamine release in the mouse: lack of cross tolerance between apomorphine, GBL and CGS 10746B.
1988
1988
CGS 10746B is able to attenuate the effects of amphetamine: Further evidence for dopaminergic mediation
Highly Cited
1986
Highly Cited
1986
CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)